BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8356718)

  • 1. Efficacy of rapamycin in orthotopic small bowel transplantation in the rat.
    Marquet RL; de Bruin RW; Heineman E; Jeekel J
    Transplant Proc; 1993 Aug; 25(4):2695-6. PubMed ID: 8356718
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
    Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
    Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
    [No Abstract]   [Full Text] [Related]  

  • 3. Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy.
    Cohen DS; Fisher RA; Shapiro JH; Goggins WC; Tawes JW; Mills S; Contos M; Ham JM; Schroeder TJ
    Transplant Proc; 1996 Oct; 28(5):2501-5. PubMed ID: 8907923
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
    Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
    Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
    [No Abstract]   [Full Text] [Related]  

  • 5. 2-Chlorodeoxyadenosine in combination with cyclosporine prevents rejection after allogeneic small bowel transplantation.
    Schmid T; Oberhuber G; Thaler W; Kaltenbacher A; Herbst P; Margreiter R; Konwalinka G
    Transplant Proc; 1994 Jun; 26(3):1614. PubMed ID: 7913269
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral leflunomide prevents small bowel allograft rejection in the rat.
    He G; McAlister VC; Lee TD; Bitter-Suermann H; Theal M; Wright J; MacDonald AS
    Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
    Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
    Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
    Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P
    Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide and cyclosporine immunomodulation in intestinal xenotransplantation.
    Foster PF; Kociss K; Shen J; Sankary HN; Xiao F; Williams JW
    Transplant Proc; 1996 Oct; 28(5):2527-8. PubMed ID: 8907935
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
    Hamashima T; Stepkowski SM; Smith S; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
    Chen H; Wu J; Luo H; Daloze P
    Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolongation by rapamycin of heart, kidney, pancreas, and small bowel allograft survival in rats.
    Stepkowski SM; Chen H; Daloze P; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):507-8. PubMed ID: 1990602
    [No Abstract]   [Full Text] [Related]  

  • 14. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G; Zhong R; Zhang Z; Garcia B; Black R; Duff J; Grant D
    Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined effect of rapamycin and cyclosporine in the prevention of rat corneal allograft rejection.
    Thompson P; Xu D; Brunette I; Chen H
    Transplant Proc; 1998 Jun; 30(4):1033-5. PubMed ID: 9636417
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined rapamycin and cyclosporine immunosuppression in a porcine renal transplant model.
    Granger DK; Cromwell JW; Canafax DM; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):984. PubMed ID: 8623488
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
    Stepkowski SM; Tu Y; Chou TC; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
    Lin Y; Waer M
    Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224
    [No Abstract]   [Full Text] [Related]  

  • 20. Brequinar sodium potentiates the effects of cyclosporine in experimental small bowel transplantation.
    Collins BH; Areford ML; Fabian MA; Jaffee BD; Bollinger RR
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):37-9. PubMed ID: 8516941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.